Detalles de la búsqueda
1.
A New Combination of Radio-Frequency Coil Configurations Using High-Permittivity Materials and Inductively Coupled Structures for Ultrahigh-Field Magnetic Resonance Imaging.
Sensors (Basel)
; 22(22)2022 Nov 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-36433565
2.
Design, synthesis and anti-inflammatory activity of imidazol-5-yl pyridine derivatives as p38α/MAPK14 inhibitor.
Bioorg Med Chem
; 31: 115969, 2021 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33422910
3.
Anticancer profile and anti-inflammatory effect of new N-(2-((4-(1,3-diphenyl-1H-pyrazol-4-yl)pyridine sulfonamide derivatives.
Bioorg Chem
; 117: 105424, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34678604
4.
Design, synthesis, and biological evaluation of novel imidazole derivatives possessing terminal sulphonamides as potential BRAFV600Einhibitors.
Bioorg Chem
; 106: 104508, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33280830
5.
Evaluation of the Inhibitory Effects of Pyridylpyrazole Derivatives on LPS-Induced PGE2 Productions and Nitric Oxide in Murine RAW 264.7 Macrophages.
Molecules
; 26(21)2021 Oct 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-34770896
6.
Modification of imidazothiazole derivatives gives promising activity in B-Raf kinase enzyme inhibition; synthesis, in vitro studies and molecular docking.
Bioorg Med Chem Lett
; 30(20): 127478, 2020 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32781217
7.
Design and synthesis of novel pyrrolo[2,3-b]pyridine derivatives targeting V600EBRAF.
Bioorg Med Chem
; 28(11): 115493, 2020 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32340792
8.
Structural optimization of imidazothiazole derivatives affords a new promising series as B-Raf V600E inhibitors; synthesis, in vitro assay and in silico screening.
Bioorg Chem
; 100: 103967, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32470760
9.
Synthesis, biological evaluation, and docking studies of new pyrazole-based thiourea and sulfonamide derivatives as inhibitors of nucleotide pyrophosphatase/phosphodiesterase.
Bioorg Chem
; 99: 103783, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32224334
10.
Antiproliferative activity of cycloalkanecarboxamide derivatives possessing sulfonate or sulfamate moiety.
Bioorg Chem
; 97: 103677, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32120075
11.
Imidazothiazole-based potent inhibitors of V600E-B-RAF kinase with promising anti-melanoma activity: biological and computational studies.
J Enzyme Inhib Med Chem
; 35(1): 1712-1726, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32962435
12.
A Study on the Effective Ratio of Fat to Stromal Vascular Fraction for Cell-Assisted Lipotransfer.
Aesthetic Plast Surg
; 44(1): 162-167, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31792563
13.
Mechanistic/mammalian target of rapamycin: Recent pathological aspects and inhibitors.
Med Res Rev
; 39(2): 631-664, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30251347
14.
Evaluation of Normal-Appearing White Matter in Multiple Sclerosis Using Direct Visualization of Short Transverse Relaxation Time Component (ViSTa) Myelin Water Imaging and Gradient Echo and Spin Echo (GRASE) Myelin Water Imaging.
J Magn Reson Imaging
; 49(4): 1091-1098, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30240519
15.
Anticancer profile of newly synthesized BRAF inhibitors possess 5-(pyrimidin-4-yl)imidazo[2,1-b]thiazole scaffold.
Bioorg Med Chem
; 27(10): 2041-2051, 2019 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30955995
16.
Thieno[2,3-d]pyrimidine as a promising scaffold in medicinal chemistry: Recent advances.
Bioorg Med Chem
; 27(7): 1159-1194, 2019 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30826188
17.
Discovery of highly potent V600E-B-RAF kinase inhibitors: Molecular modeling study.
Bioorg Med Chem
; 27(4): 655-663, 2019 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30660499
18.
Design, synthesis, and anticancer activity of imidazo[2,1-b]oxazole-based RAF kinase inhibitors.
Bioorg Chem
; 93: 103349, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31627060
19.
Design, synthesis, in vitro potent antiproliferative activity, and kinase inhibitory effects of new triarylpyrazole derivatives possessing different heterocycle terminal moieties.
J Enzyme Inhib Med Chem
; 34(1): 1534-1543, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31452407
20.
Design, synthesis, in vitro anticancer evaluation, kinase inhibitory effects, and pharmacokinetic profile of new 1,3,4-triarylpyrazole derivatives possessing terminal sulfonamide moiety.
J Enzyme Inhib Med Chem
; 34(1): 97-109, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30362383